BMO Capital analyst R. Scott Graham raised his price target on Actuant to $27, saying the company produced a good Q3 earnings report after 14 consecutive earnings declines even though it reduced its outlook. Graham notes that the key was a "merciful turn" in the Energy segment, where lower costs generated improved profitability, while the management's sales growth strategies are also starting to impact the company's top line. The analyst keeps his Market Perform rating on Actuant, adding that the subsequent rise in the stock price has discounted the strong quarter of better free cash flows, leaving the stock "fully valued".